Male contraception is being put to the test in Manchester and Edinburgh, where couples are being invited to take part in a ground-breaking international study trialling a new form of male contraception. More: Male contraception being tested in Manchester and
read moreEver wish you could be a fly on the wall at a company in the middle of a merger? Thanks to the Securities and Exchange Commission, you can—at a Bristol-Myers Squibb town hall about its Celgene buyout, at least. Hint:
read moreJohnson & Johnson is counting on Erleada to carry the prostate cancer baton as Zytiga battles generics. And thanks to an early trial win, it just got one step closer to a new indication. More: Johnson & Johnson's Erleada trial
read moreBiologics CDMO Samsung BioLogics has kept up its frantic growth even as it deals with legal issues tied to its joint venture with Biogen. More: Samsung BioLogics sees sales rise but profit fall as it continues expansion Source: fierce
read moreSens. Bill Cassidy and Mark Warner have introduced a bill designed to encourage pharma companies to strike deals with insurers that allow them to spread payments for expensive therapies over time, with installments potentially tied to patient outcomes. Some analysts
read moreJapan’s Hitachi, which is trying to forge a leadership position as a CDMO in regenerative and cell therapies, already has facilities in the U.S. Now it is making a move into Europe. More: Hitachi gets EU cell manufacturing facilities with
read more© 1994 - 2024 B.M. Pharmaceuticals